BiotechTube

DS-1040b + Clopidogrel

Phase 1Completed
1 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Drug Interaction

Conditions

Drug Interaction

Trial Timeline

Dec 1, 2015 → Mar 1, 2016

NCT ID
NCT02560688

About DS-1040b + Clopidogrel

DS-1040b + Clopidogrel is a phase 1 stage product being developed by Daiichi Sankyo for Drug Interaction. The current trial status is completed. This product is registered under clinical trial identifier NCT02560688. Target conditions include Drug Interaction.

What happened to similar drugs?

8 of 15 similar drugs in Drug Interaction were approved

Approved (8) Terminated (3) Active (5)
✅CefiderocolShionogiApproved
✅OnabotulinumtoxinA 145 UNT [Botox]AbbVieApproved
✅Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mLNovartisApproved
✅Oseltamivir + WarfarinRocheApproved
✅Rivaroxaban 20mg + Sotorasib 960mgAmgenApproved
✅Polyene phosphatidylcholine injection 930 mg QD + Magnesium Isoglycyrrhizinate injection 200 mg QDHaisco Pharmaceutical GroupApproved
✅AZILECT® + PlaceboLundbeckApproved

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT02560688Phase 1Completed

Competing Products

20 competing products in Drug Interaction

See all competitors
ProductCompanyStageHype Score
ORIN1001Fosun PharmaPhase 1/2
32
GP404141 + NplateGEROPHARMPhase 3
34
Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)YuhanPhase 1
29
Tolbutamide + Midazolam + PexidartinibDaiichi SankyoPhase 1
29
DS-8500a + RosuvastatinDaiichi SankyoPhase 1
29
EC905 + verapamilAstellas PharmaPhase 1
29
rosuvastatin + fidaxomicinAstellas PharmaPhase 1
29
enzalutamide + rifampinAstellas PharmaPhase 1
29
ASP3652 + Gemfibrozil + RepaglinideAstellas PharmaPhase 1
29
CefiderocolShionogiApproved
50
Placebo + Active Comparator #1 + Active Comparator #2 + Active Comparator #3 + Lorcaserin Dose #1 + Lorcaserin Dose #2 + Lorcaserin Dose #3EisaiPhase 1
29
Istradefylline + Phentermine 45 mgKyowa KirinPhase 1
29
Lasmiditan + Alprazolam + PlaceboEli LillyPhase 1
29
Nasal Glucagon (NG) + Glucagon IMEli LillyPhase 3
40
napabucasin + cytochrome P450 (CYP450) probe drugs or BCRP transporter substrateSumitomo PharmaPhase 1
29
Norgestimate; Ethinyl Estradiol; Folic acidJohnson & JohnsonPhase 1
29
Norgestimate; Ethinyl Estradiol; Folic acidJohnson & JohnsonPhase 1
29
Loperamide / Red Grapefruit Juice + Loperamide/ White Grapefruit Juice + Loperamide / Pink Grapefruit JuiceJohnson & JohnsonPhase 1
29
HR17031 injection + insulin glargineJiangsu Hengrui MedicinePhase 3
40
Pyrotinib Maleate + EfavirenzJiangsu Hengrui MedicinePhase 1
25